MRI预测脑胶质瘤异柠檬酸脱氢酶基因型:单壳与多壳扩散模型的比较
这项前瞻性观察研究纳入192例连续受试者(II级62例、III级58例、IV级72例),术前进行扩散MRI(b=700和2000 sec/mm2),比较DTI、扩散峰度成像和NODDI指标与IDH基因型的相关性。结果显示在II和III级IDH野生型胶质瘤中,最大各向异性分数、峰度各向异性和限制分数显著高于IDH突变型,最小平均扩散率显著低于IDH突变型(P值分别为.011、.002、.044和.027),AUC范围为0.72至0.76;高级扩散MRI模型未增加诊断准确性,支持在脑肿瘤成像方案中纳入单壳扩散张量成像采集。
要点
- II和III级IDH野生型胶质瘤的最大各向异性分数、峰度各向异性和限制分数显著高于IDH突变型,最小平均扩散率显著低于IDH突变型。
- 上述指标鉴别IDH基因型的AUC范围为0.72至0.76。
- 高级扩散MRI模型未比DTI增加诊断准确性,支持脑肿瘤成像方案纳入单壳DTI采集。
核心结论
- 扩散MRI指标与II和III级胶质瘤的IDH状态相关,高级扩散MRI模型未增加诊断准确性,支持在脑肿瘤成像方案中纳入单壳扩散张量成像采集。
研究设计与样本
- 前瞻性观察研究,纳入192例连续受试者(113例男性、79例女性;平均年龄46.18岁;年龄范围14-77岁),包括II级62例、III级58例、IV级72例胶质瘤,术前进行扩散MRI(b=700和2000 sec/mm2),测量DTI、扩散峰度成像和NODDI指标。
诊断标准与关键数值
- 在II和III级IDH野生型胶质瘤中,最大各向异性分数、峰度各向异性和限制分数显著高于IDH突变型,最小平均扩散率显著低于IDH突变型(P值分别为.011、.002、.044和.027),AUC范围为0.72至0.76。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose The primary aim of this prospective observational study was to assess whether diffusion MRI metrics correlate with isocitrate dehydrogenase (IDH) status in grade II and III gliomas. A secondary aim was to investigate whether multishell acquisitions with advanced models such as neurite orientation dispersion and density imaging (NODDI) and diffusion kurtosis imaging offer greater diagnostic accuracy than diffusion-tensor imaging (DTI). Materials and Methods Diffusion MRI (b = 700 and 2000 sec/mm2) was performed preoperatively in 192 consecutive participants (113 male and 79 female participants; mean age, 46.18 years; age range, 14-77 years) with grade II (n = 62), grade III (n = 58), or grade IV (n = 72) gliomas. DTI, diffusion kurtosis imaging, and NODDI metrics were measured in regions with or without hyperintensity on diffusion MR images and compared among groups defined according to IDH genotype, 1p/19q codeletion status, and tumor grade by using Mann-Whitney tests. Results In grade II and III IDH wild-type gliomas, the maximum fractional anisotropy, kurtosis anisotropy, and restriction fraction were significantly higher and the minimum mean diffusivity was significantly lower than in IDH-mutant gliomas (P = .011, P = .002, P = .044, and P = .027, respectively); areas under the receiver operating characteristic curve ranged from 0.72 to 0.76. In IDH wild-type gliomas, no difference among grades II, III, and IV was found. In IDH-mutant gliomas, no difference between those with and those without 1p/19q loss was found. Conclusion Diffusion MRI metrics showed correlation with isocitrate dehydrogenase status in grade II and III gliomas. Advanced diffusion MRI models did not add diagnostic accuracy, supporting the inclusion of a single-shell diffusion-tensor imaging acquisition in brain tumor imaging protocols. Published under a CC BY 4.0 license. Online supplemental material is available for this article.
引用
- Figini M, Riva M, Graham M, et al. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models. Radiology. 2018. PMID: 30277427. doi:10.1148/radiol.2018180054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。